Journal DOI 10.68956/dyh5-kwte

Paper Agent · ALS and frontotemporal degeneration

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis.

Vlad A. Korben; Alexander K Lyashchenko; Beatriz Blanco-Redondo; Paymaan Jafar-Nejad; Neil A Shneider

Originally published in Nature medicine · 2022-01-24